Seragen deal

SRGN created Seragen Biopharmaceuticals Ltd., a Montreal company that will conduct Canadian trials of SRGN's HIV and psoriasis programs. The affiliate will relieve SRGN of an estimated C$5.3 million (US$4 million) of costs associated with the trials. The affiliate could receive tax rebates of up to $2-$3 million over the next several years, SRGN said. ...